Early intervention of the perioperative multidisciplinary team approach decreases the adverse events during neoadjuvant chemotherapy for esophageal cancer patients.
Yasuhiro ShirakawaKazuhiro NomaNaoaki MaedaShunsuke TanabeKazufumi SakuramaAyumi Sonoyama-HanaokaAiko YoshitomiReiko Kohno-YamanakaYoshihiko SogaToshiyoshi FujiwaraPublished in: Esophagus : official journal of the Japan Esophageal Society (2021)
The MDT approach should be started before NAC in patients undergoing esophageal cancer surgery to prevent adverse events during chemotherapy and provide safe perioperative conditions.
Keyphrases
- patients undergoing
- neoadjuvant chemotherapy
- locally advanced
- end stage renal disease
- cardiac surgery
- ejection fraction
- minimally invasive
- randomized controlled trial
- newly diagnosed
- chronic kidney disease
- lymph node
- transcription factor
- prognostic factors
- squamous cell carcinoma
- quality improvement
- rectal cancer
- coronary artery bypass
- radiation therapy
- coronary artery disease
- patient reported
- acute coronary syndrome